Inventor · disambiguated record
Yossef Kliger
Also filed as: KLIGER YOSSEF
9 granted patents·8 pending applications·58 citations·filing 2003–2023
84Inventor score
Top patents by PatentIndex Score
17 records- 0187US7573031B2Methods for SEM inspection of fluid containing samplesQUANTOMIX LTD·Filed 2007·Granted Aug 11, 2009·21 cites·9 claims
- 0283US8529943B2Angiopoietin derived peptidesKLIGER YOSSEF·Filed 2009·Granted Sep 10, 2013·10 cites·17 claims
- 0383US7230242B2Methods for SEM inspection of fluid containing samplesQUANTOMIX LTD·Filed 2003·Granted Jun 12, 2007·25 cites·22 claims
- 0481US2024025973A1Pvrig polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 0578US10550173B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2016·Granted Feb 4, 2020·2 cites·10 claims
- 0672US2024287174A1Hide1 compositions and methodsCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 0770US11795209B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2020·Granted Oct 24, 2023·0 cites·15 claims
- 0866US8575107B2Clusterin derived peptideKLIGER YOSSEF·Filed 2009·Granted Nov 5, 2013·0 cites·6 claims
- 0959US8987191B2Bioactive peptides and methods of using sameCOMPUGEN LTD·Filed 2013·Granted Mar 24, 2015·0 cites·24 claims
- 1054US8512708B2GP96 derived peptidesKLIGER YOSSEF·Filed 2009·Granted Aug 20, 2013·0 cites·4 claims
- 1154US2016272707A1Vstm5 antibodies, and uses thereof for treatment of cancer, infectious diseases and immune related diseasesCOMPUGEN LTD·Filed 2014·Application pending·0 cites
- 1254US2023400467A1Pvrl2 and/or pvrig as biomarkers for treatmentCOMPUGEN LTD·Filed 2021·Application pending·0 cites
- 1353US9255132B2Angiopoietin derived peptidesCOMPUGEN LTD·Filed 2013·Granted Feb 9, 2016·0 cites·27 claims
- 1448US2018305451A1Hide1 compositions and methodsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 1545US2015307572A1Bioactive peptides and methods of using sameCOMPUGEN LTD·Filed 2015·Application pending·0 cites
- 1639US2016347814A1Vstm5 polypeptides and uses thereof as a drug for treatment of cancer, infectious diseases and immune related diseasesCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 1732US2006052301A1Splice variants of peptide YY, neuropeptide Y, pancreatic peptide Y and Amylin, and uses thereofSHEMESH RONEN·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →